This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.
The decree defines the health benefit package of the universal health insurance scheme.
These regulations were developed in the exercise of the powers conferred by sections 24, 30, 46)2), 47(5) and 50(1) of the Social Health Insurance Act, 2023, by the Cabinet Secretary for Health, in consultation with the Board for the Social Health Authority.
The Decree establishes the health benefit package covered under the Universal Health Insurance. The decree was published on 25 November 2023 in the Official Journal.
The executive Decree No 22-401 of 26 Rabie Ethani 1444 establishes the composition, organization and operation of the National Health Observatory. It was published in the Official Journal of 24 November 2022 (pages 7 -10).
Décret No 22/16 portant organisation et fonctionnement d'un Etablissement public dénommé Institut National de Santé Publique
This Decree regulates the organization and operation of a public establishment called the National Institute of Public Health. This document is published as a part of the Official Journal and the Decree is located on page 31 of the file.
The Decree specifies the application of certain provisions of the law establishing the Universal Health Insurance Scheme, such as affiliation and registration, the insured person's card, care benefits covered, the assumption of responsibility for benefits, health care providers, among other aspects.
The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.
This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)
This document provides the benefits package of the National Health Insurance Scheme as offered to its beneficiaries through private health providers.
The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.
The decree regulates the establishment, organization and functioning of the National Public Health Institute of Burundi.
These Instructions establish the methodology to determine the community-based health insurance benefit package.
This law establishes a universal health insurance in the Togolese Republic.
Decreto No 115/2020 Aprova o Estatuto Orgânico da Autoridade Nacional Reguladora de Medicamento
The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.
This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.
The Ordinance creates a national public scientific and technological establishment called the "Institut national de Santé Publique" (National Institute of Public Health). The mission of the Institut National de Santé Publique is to set up a health monitoring and epidemiological surveillance system, and to promote research into health policies and systems.
The Decree rules on the organization and operating procedures of the National Institute of Public Health created by Ordinance n°2019-011/P-RM of March 27, 2019 creating the National Institute of Public Health.
The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).
The National Medical Supplies Agency Act
This Act repeals and replaces the National Pharmaceutical Procurement Unit Act, 2012 to establish the National Medical Supplies Agency as a public service agency responsible for the procurement, warehousing and distribution of drugs and medical supplies in a transparent and cost-effective manner for and on behalf of all public institutions throughout Sierra Leone.